December 5, 2017
Xultophy reported a better option than basal-bolus insulin therapy to manage type 2 diabetes by DUAL VII trial
It was reported by the certain people with type 2 diabetes that once-daily Xultophy (insulin degludec/liraglutide) was a better option…